---
figid: PMC9669388__fphar-13-1040350-g002
figtitle: 'Astragalus and its formulas as a therapeutic option for fibrotic diseases:
  Pharmacology and mechanisms'
organisms:
- Astragalus mongholicus
- Mus musculus
- Rattus norvegicus
- Coxsackievirus B3
- Schisandra sphenanthera
- Engelhardia roxburghiana
- herbal medicine
- Angelica sinensis
- Salvia miltiorrhiza
- Candida dubliniensis
- Euonymus alatus
- Glehnia littoralis
- Reynoutria japonica
- Glycyrrhiza glabra
- Schisandra chinensis
- Echinacea purpurea
- Astragalus membranaceus
- Opsanus beta
- Homo sapiens
- Canis lupus familiaris
- Oryctolagus cuniculus
- NA
- NA
organisms_ner:
- Canis lupus familiaris
- Oryctolagus cuniculus
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC9669388
filename: fphar-13-1040350-g002.jpg
figlink: /pmc/articles/PMC9669388/figure/F2/
number: F2
caption: Astragalus exerts antifibrosis effects by inhibiting EMT, ROS, TGF-β1/Smads,
  apoptosis, and inflammation pathways. ASIV is the main antifibrotic component of
  Astragalus. ASIV downregulates mir-21/Wnt/β-catenin/EMT pathway (), TGF-β1/PI3K/AKT/Foxo3a/EMT
  pathway (), and sirt1 AS/EMT pathway (). ASIV also regulates mir-135a/TGF-β/Smads
  pathway (). ASIV reduces oxidative stress by upregulating p62/Keap1/Nrf2 pathway
  (), ASIV enhances Nrf2 signaling to inhibit ROS-induced ferroptosis (). In addition,
  ASIV can modulate MAPK and NF-κB signaling pathways to inhibit inflammation and
  apoptosis (; ; ; ). ASIV inhibits NLRP3/caspase1 pathway (; ). ASIV downregulates
  FAS/FASL pathway to inhibit apoptosis (). ASIV also reduces TNF-α and IL-6 expression
  to inhibit inflammation (). Cal can suppress TGFBR1 signaling pathway (). Cal also
  modulates PI3K/AKT and IL33/ST2 pathways to suppress inflammation (; ). Cal activates
  FXR to reduce triglyceride (). Cal reduces ROS and balances MMP-1/TIMP-1 system
  to inhibit collagen synthesis (). AI inhibits Jagged1/Notch1//TGF-β1/Smads/EMT and
  TGF-β1/NADPH oxidase/ROS pathways (; ), AI can reduce MCP-1 expression to inhibit
  inflammation (). FORM can regulate sirt1/Nrf2/ARE/ROS signaling pathway (). AM modulates
  Smad7/β-catenin/EMT pathway (). AS regulates numb/Notch/TGF-β1 pathway (). APS inhibits
  TGF-β1/ILK pathway to reduce inflammation (). ATS modulates PGC-1α and Bax/Bcl2/caspase3
  pathway to inhibit apoptosis ().
papertitle: 'Astragalus and its formulas as a therapeutic option for fibrotic diseases:
  Pharmacology and mechanisms.'
reftext: Yi Zhu, et al. Front Pharmacol. 2022;13:1040350.
year: '2022'
doi: 10.3389/fphar.2022.1040350
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: Astragalus mongholicus Bunge | active components | fibrosis | anti-fibrosis
  effects | traditional Chinese medicine
automl_pathway: 0.9228551
figid_alias: PMC9669388__F2
figtype: Figure
redirect_from: /figures/PMC9669388__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9669388__fphar-13-1040350-g002.html
  '@type': Dataset
  description: Astragalus exerts antifibrosis effects by inhibiting EMT, ROS, TGF-β1/Smads,
    apoptosis, and inflammation pathways. ASIV is the main antifibrotic component
    of Astragalus. ASIV downregulates mir-21/Wnt/β-catenin/EMT pathway (), TGF-β1/PI3K/AKT/Foxo3a/EMT
    pathway (), and sirt1 AS/EMT pathway (). ASIV also regulates mir-135a/TGF-β/Smads
    pathway (). ASIV reduces oxidative stress by upregulating p62/Keap1/Nrf2 pathway
    (), ASIV enhances Nrf2 signaling to inhibit ROS-induced ferroptosis (). In addition,
    ASIV can modulate MAPK and NF-κB signaling pathways to inhibit inflammation and
    apoptosis (; ; ; ). ASIV inhibits NLRP3/caspase1 pathway (; ). ASIV downregulates
    FAS/FASL pathway to inhibit apoptosis (). ASIV also reduces TNF-α and IL-6 expression
    to inhibit inflammation (). Cal can suppress TGFBR1 signaling pathway (). Cal
    also modulates PI3K/AKT and IL33/ST2 pathways to suppress inflammation (; ). Cal
    activates FXR to reduce triglyceride (). Cal reduces ROS and balances MMP-1/TIMP-1
    system to inhibit collagen synthesis (). AI inhibits Jagged1/Notch1//TGF-β1/Smads/EMT
    and TGF-β1/NADPH oxidase/ROS pathways (; ), AI can reduce MCP-1 expression to
    inhibit inflammation (). FORM can regulate sirt1/Nrf2/ARE/ROS signaling pathway
    (). AM modulates Smad7/β-catenin/EMT pathway (). AS regulates numb/Notch/TGF-β1
    pathway (). APS inhibits TGF-β1/ILK pathway to reduce inflammation (). ATS modulates
    PGC-1α and Bax/Bcl2/caspase3 pathway to inhibit apoptosis ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMAD7
  - CTNNB1
  - SIRT1
  - MIR21
  - FOXO3
  - GSK3B
  - KEAP1
  - GPX4
  - HMOX1
  - NOTCH1
  - CASQ2
  - CA1
  - SMAD2
  - SMAD3
  - NUMB
  - ILK
  - GSDMD
  - NLRP3
  - TLR4
  - TNF
  - IL18
  - IL6
  - FASLG
  - FAS
  - BAX
  - BCL2
  - IL33
  - MMP1
  - TIMP1
  - NFE2L2
  - MCP-1
  - BCL-2
  - ITK
  - SLC22A3
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - GTF2H1
  - SQSTM1
  - KHDRBS1
  - NUP62
  - DCTN4
  - GABPA
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - DECR1
  - KLK3
  - SH2B2
  - FBLIM1
  - GOPC
  - SLC25A10
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - ACTA1
  - CHUK
  - IKBKB
  - NFKB1
  - FASN
  - CCL2
  - NR1H4
  - PPARGC1A
  - ST2
  - SULT2A1
  - IL1RL1
  - SDCBP2
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - SLC2A10
  - am
  - Smad7
  - Ctnnb1
  - Itk
  - Slc22a3
  - Sirt1
  - Mir21a
  - Foxo3
  - Gsk3b
  - Keap1
  - Gtf2h1
  - Nup62
  - Sqstm1
  - Khdrbs1
  - Dctn4
  - Nfe2l2
  - Alpha-re
  - Gpx4
  - Gpx4-ps2
  - Hmox1
  - Pik3r1
  - Akt1
  - Notch1
  - Decr1
  - Klkb1
  - Sh2b2
  - S100a11
  - Fblim1
  - Gopc
  - Car1
  - Smad2
  - Smad3
  - Dync1i1
  - Slc25a10
  - Numb
  - Ilk
  - Gsdmd
  - Acta2
  - Nlrp3
  - Casp3
  - Tlr4
  - Chuk
  - Ikbkb
  - Nfkb1
  - Tnf
  - Il18
  - Il6
  - Fasl
  - Fas
  - Fasn
  - Mcpt1
  - Ccl2
  - Nr1h4
  - Bax
  - Nkx3-1
  - Bcl2
  - Ppargc1a
  - Il1rl1
  - Il33
  - Mmp13
  - Timp1
  - Wnt2
  - Mir21
  - Pik3cg
  - Mir135a
  - Faslg
  - Sult2a1
  - Mmp1
  - Dad
  - arm
  - form3
  - Wnt5
  - Wnt4
  - wg
  - sgg
  - Axn
  - gskt
  - ref(2)P
  - DCTN4-p62
  - Tfb1
  - Taf6
  - how
  - cnc
  - Ho
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Aps
  - cal
  - Cam
  - Smox
  - dic
  - sw
  - numb
  - MKP-4
  - p38b
  - rl
  - as
  - Decay
  - Toll-4
  - IKKbeta
  - Dif
  - dl
  - Rel
  - egr
  - Fas2
  - FASN1
  - Fas3
  - fand
  - tei
  - rg
  - FASN2
  - FASN3
  - Fmr1
  - fzr
  - Debcl
  - srl
  - St2
  - Timp
  - ats
  - Al
  - NADPH
  - NADP
  - Triglyceride
  - ATS
  - Fibrosis
---
